Astria Therapeutics, Inc.
ATXS
Revenue
250.00k
0.000.00%
3 Months ChangeAssets
367.99M
▼-10.82M▼-2.86%
3 Months ChangeLiabilities
20.91M
▲9.84M▲88.87%
3 Months ChangeFree Cash Flow
-13.26M
▼-4.52M▼-51.75%
24 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-12
Form 10-Q
ID: 0001410578-24-001308
2024-06-06
Form 8-K
ID: 0001104659-24-069064
2024-05-09
Form 10-Q
ID: 0001410578-24-000691
2024-04-09
Form 8-K
ID: 0001104659-24-045001
2024-03-25
Form 8-K
ID: 0001104659-24-038165
2024-03-04
Form 8-K
ID: 0001104659-24-030539
2024-01-31
Form 8-K
ID: 0001104659-24-008573
2024-01-30
Form 8-K
ID: 0001104659-24-007927
2024-01-05
Form 8-K
ID: 0001104659-24-001632
2023-12-20
Form 8-K
ID: 0001104659-23-127743